1![Microsoft Word - final_150414_e.docx Microsoft Word - final_150414_e.docx](https://www.pdfsearch.io/img/3bd40d9e571fa1944148649a73713af9.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2015-04-14 05:34:23
|
---|
2![For Immediate Release Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients with Type 2 Diabetes at the American Diabetes Association Meeting TOKYO, JAPAN, June 28, 2010 – A For Immediate Release Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients with Type 2 Diabetes at the American Diabetes Association Meeting TOKYO, JAPAN, June 28, 2010 – A](https://www.pdfsearch.io/img/a14808a8c7bccceb30fefc7c113bed10.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2010-06-27 23:10:21
|
---|
3![MISSISSIPPI DIVISION OF MEDICAID Pharmacy & Therapeutics Committee Woolfolk Building Conference Center East, Room 145 Jackson, MS[removed]February 10, 2015 MISSISSIPPI DIVISION OF MEDICAID Pharmacy & Therapeutics Committee Woolfolk Building Conference Center East, Room 145 Jackson, MS[removed]February 10, 2015](https://www.pdfsearch.io/img/6d8516bb5082cc75807b076f9cb3e7ed.jpg) | Add to Reading ListSource URL: www.medicaid.ms.govLanguage: English - Date: 2015-01-16 15:00:31
|
---|
4![For Immediate Release Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients with Type 2 Diabetes at the European Association for the Study of Diabetes Meeting TOKYO, September For Immediate Release Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients with Type 2 Diabetes at the European Association for the Study of Diabetes Meeting TOKYO, September](https://www.pdfsearch.io/img/b543824947dab1a02d53cd1197294e51.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2011-09-15 04:30:05
|
---|
5![September 2, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of CANAGLU® Tablets 100mg September 2, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of CANAGLU® Tablets 100mg](https://www.pdfsearch.io/img/629ef0c7bf483f1e47835541f39b20d5.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2014-09-01 04:59:05
|
---|
6![September 2, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of CANAGLU® Tablets 100mg September 2, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of CANAGLU® Tablets 100mg](https://www.pdfsearch.io/img/b74fa00e2d257e7cf2db8ad5f88b678e.jpg) | Add to Reading ListSource URL: www.daiichisankyo.comLanguage: English - Date: 2014-09-21 22:38:31
|
---|
7![Microsoft Word - 20140704_Approval for CANAGLU_E_Final.doc Microsoft Word - 20140704_Approval for CANAGLU_E_Final.doc](https://www.pdfsearch.io/img/32aa1bb5787ebcb02b35716ba5c97ec4.jpg) | Add to Reading ListSource URL: www.daiichisankyo.comLanguage: English - Date: 2014-07-09 23:53:06
|
---|
8![田辺三菱製薬プレスリリース・テンプレート設定用 田辺三菱製薬プレスリリース・テンプレート設定用](https://www.pdfsearch.io/img/05ab3b20b1ec7970a7a9cc0aceeaf9ab.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2013-05-26 10:08:55
|
---|
9![July 4, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval in Japan Received for July 4, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval in Japan Received for](https://www.pdfsearch.io/img/b36633dc9aa4dcea9b6764f50be7e554.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2014-07-04 01:18:30
|
---|
10![Int. J. Biol. Sci. 2014, Vol. 10 Ivyspring Int. J. Biol. Sci. 2014, Vol. 10 Ivyspring](https://www.pdfsearch.io/img/d827a783171b8069c0ce6396cf4a1e9f.jpg) | Add to Reading ListSource URL: www.ijbs.comLanguage: English - Date: 2014-05-28 19:24:40
|
---|